Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
for Head and Neck Cancer
1 location in Bethesda
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18 - 120
Code: NCT07667400·Phase 1, Phase 2·Not Yet Recruiting·Listed Jun 25, 2026